1-3 of 3
Alvin Wong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Carfilzomib in Patients (Pts) with Relapsed and Refractory Multiple Myeloma (MM) and Varying Degrees of Renal Insufficiency.

Ashraf Z. Badros, MD, Ravi Vij, MD, Thomas Martin, MD, Jeffrey A Zonder, MD, Tina Woo, Zhengping Wang, Susan Lee, Alvin Wong, PharmD, Ruben Niesvizky, MD
Journal: Blood
Blood (2009) 114 (22): 3877.
https://doi.org/10.1182/blood.V114.22.3877.3877
Published: 2009
Journal Articles

The Prodrug AQ4N Displays Potent Anti-Tumor Activity in a Xenotransplantation Model of Primary Human Acute Lymphoblastic Leukemia.

Bart A. Nijmeijer, Marianke L.J. Van Schie, Susan E. Alters, Alvin Wong, Jeffrey L. Cleland, Roelof Willemze, J.H. Frederik Falkenburg
Journal: Blood
Blood (2005) 106 (11): 1837.
https://doi.org/10.1182/blood.V106.11.1837.1837
Published: 2005
Journal Articles

A Novel N-Oxide Drug, AQ4N, Has In Vitro Activity in Lymphoma and Leukemia Cell Lines and Selectively Targets Lymphocytes and Lymphatic Tissues in Vivo.

Jeffrey L. Cleland, Ph.D., Alvin Wong, Pharm.D., Susan E. Alters, Ph.D., Peter A. Harris, M.D., Chris R. Dunk, B.S., John G. Curd, M.D., Robert L. Capizzi, M.D., William D. Henner, M.D.
Journal: Blood
Blood (2004) 104 (11): 2498.
https://doi.org/10.1182/blood.V104.11.2498.2498
Published: 2004